Prosurvival Bcl-2 family members reveal a distinct apoptotic identity between conventional and plasmacytoid dendritic cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 13, 2015, Pages 4044-4049

  Carrington, Emma M ^a,b   Zhang, Jian Guo ^a,b   Sutherland, Robyn M ^a,b   Vikstrom, Ingela B ^a,b   Brady, Jamie L ^a,b   Soo, Priscilla ^a   Vremec, David ^a   Allison, Cody ^a,b   Lee, Erinna F ^a,b   Fairlie, W Douglas ^a,b   Bouillet, Philippe ^a,b   Grabow, Stephanie ^a,b   Ottina, Eleonora ^a,b,c   Herold, Marco J ^a,b   Pellegrini, Marc ^a,b   Huang, David C S ^a,b   Tarlinton, David M ^a,b   Strasser, Andreas ^a,b   Lew, Andrew M ^a,b   Zhan, Yifan ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Apoptosis; BH3 mimetic; Dendritic cells

Indexed keywords

BCL2 RELATED PROTEIN A1; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; VENETOCLAX; BCL2 PROTEIN, MOUSE; BCL2L1 PROTEIN, MOUSE; MCL1 PROTEIN, MOUSE; PROTEIN BCL X;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; CONVENTIONAL DENDRITIC CELL; DENDRITIC CELL; DRUG ANTAGONISM; GENE OVEREXPRESSION; GENE SILENCING; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL SEPARATION; CYTOLOGY; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE;

MUS;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL SEPARATION; CELL SURVIVAL; DENDRITIC CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES; TRANSGENES;

EID: 84961291216     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1417620112     Document Type: Article

References (43)

1. Jung S, et al. (2002) In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17(2):211-220.
2. Anandasabapathy N, et al. (2014) Classical Flt3L-dependent dendritic cells control immunity to protein vaccine. J Exp Med 211(9):1875-1891.
3. Chen M, et al. (2006) Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311(5764):1160-1164.
4. Chen M, Huang L, Shabier Z, Wang J (2007) Regulation of the lifespan in dendritic cell subsets. Mol Immunol 44(10):2558-2565.
5. Steinman RM (2012) Decisions about dendritic cells: Past, present, and future. Annu Rev Immunol 30:1-22.
6. Lauterbach H, et al. (2010) Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med 207(12):2703-2717.
7. Liu YJ (2005) IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275-306.
8. Villadangos JA, Young L (2008) Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29(3):352-361.
9. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8(8):594-606.
10. Baccala R, et al. (2013) Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc Natl Acad Sci USA 110(8): 2940-2945.
11. Kamath AT, et al. (2000) The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 165(12):6762-6770.
12. Merad M, Manz MG (2009) Dendritic cell homeostasis. Blood 113(15):3418-3427.
13. Marsden VS, Strasser A (2003) Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 21:71-105.
14. Youle RJ, Strasser A (2008) The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9(1):47-59.
15. Carrington EM, et al. (2010) BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. Proc Natl Acad Sci USA 107(24):10967-10971.
16. Kile BT (2014) The role of apoptosis in megakaryocytes and platelets. Br J Haematol 165(2):217-226.
17. Pierson W, et al. (2013) Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells. Nat Immunol 14(9):959-965.
18. Vikstrom I, et al. (2010) Mcl-1 is essential for germinal center formation and B cell memory. Science 330(6007):1095-1099.
19. Oltersdorf T, et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435(7042):677-681.
20. Souers AJ, et al. (2013) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19(2):202-208.
21. Ogilvy S, et al. (1999) Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 96(26):14943-14948.
22. Vremec D, et al. (2015) Maintaining dendritic cell viability in culture. Mol Immunol 63(2):264-267.
23. Ottina E, et al. (2012) Targeting antiapoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice. Blood 119(25):6032-6042.
24. Rinkenberger JL, Horning S, Klocke B, Roth K, Korsmeyer SJ (2000) Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev 14(1):23-27.
25. Okamoto T, et al. (2014) Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis. Proc Natl Acad Sci USA 111(1):261-266.
26. Peperzak V, et al. (2013) Mcl-1 is essential for the survival of plasma cells. Nat Immunol 14(3):290-297.
27. Edelson BT, et al. (2011) Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization. PLoS ONE 6(10):e25660.
28. Jiao Z, et al. (2014) The closely related CD103+ dendritic cells (DCs) and lymphoidresident CD8+ DCs differ in their inflammatory functions. PLoS ONE 9(3):e91126.
29. O'Keeffe M, et al. (2002) Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J Exp Med 196(10):1307-1319.
30. Herold MJ, et al. (2006) The stability and anti-apoptotic function of A1 are controlled by its C terminus. J Biol Chem 281(19):13663-13671.
31. Nopora A, Brocker T (2002) Bcl-2 controls dendritic cell longevity in vivo. J Immunol 169(6):3006-3014.
32. Hou WS, Van Parijs L (2004) A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol 5(6):583-589.
33. Lessene G, et al. (2013) Structure-guided design of a selective BCL-X(L) inhibitor. Nat Chem Biol 9(6):390-397.
34. Zhan Y, et al. (2014) BCL-2 antagonists kill plasmacytoid dendritic cells of lupus-prone mice and dampen IFN-α production. Arthritis Rheum (Munch) 2014(Nov):21 10.1002/ art.38966.
35. Karrich JJ, et al. (2012) The transcription factor Spi-B regulates human plasmacytoid dendritic cell survival through direct induction of the antiapoptotic gene BCL2-A1.Blood 119(22):5191-5200.
36. Chen M, Huang L, Wang J (2007) Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 109(10):4360-4367.
37. Fuertes Marraco SA, et al. (2011) Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS ONE 6(6): e20189.
38. Rönnblom L, Alm GV (2001) A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 194(12): F59-F63.
39. Bardwell PD, et al. (2009) The Bcl-2 family antagonist ABT-737 significantly inhibits multiple animal models of autoimmunity. J Immunol 182(12):7482-7489.
40. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M (2010) Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33(6):955-966.
41. Cippà PE, et al. (2012) Resistance to ABT-737 in activated T lymphocytes: Molecular mechanisms and reversibility by inhibition of the calcineurin-NFAT pathway. Cell Death Dis 3:e299.
42. Koenen P, et al. (2013) Mutually exclusive regulation of T cell survival by IL-7R and antigen receptor-induced signals. Nat Commun 4:1735.
43. Vandenberg CJ, Cory S (2013) ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. Blood 121(12):2285-2288.